December 1, 2021

East Valley Times

Complete News World

Amazing discovery of astrogenic antibodies

Advances in science around Corona virus Increasingly, as knowledge about the disease becomes more and more accurate, the options for dealing with the infection will increase. Scientists from the pharmaceutical company responsible for production Astrogenogen The combination of long-acting monoclonal antibodies has been shown to significantly reduce the risk of developing COVID-19; Both prevention Virus As in treatment.

Two new experiments were carried out in Phase II Astrogenogen The combination of long-acting monoclonal antibodies has been shown to greatly reduce the risk of developing. Corona virus; In both antiviral prevention and treatment. The effectiveness of this intramuscular dose has reached 83% and it has a lasting effect.

Titles